ARCH Venture Partners
Venture capital firm · Founded 1985 · Chicago, IL · Chicago ↗
Chicago-based venture firm investing in early-stage life sciences, physical sciences and information technology companies, often built around scientific founders.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at ARCH Venture Partners, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
LAST CHECKED NOV 2026
Latest fund
ARCH Venture Fund XIII$3B · 2024
Funds
13
Check size
LAST CHECKED NOV 2026
Stages
SeedSeries ASeries B
Sectors
life sciencesbiotechphysical sciences
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
- Illuminaipo
DNA-sequencing company; ARCH co-founder Robert Nelsen was an initial investor per GeekWire's Midas profile.
Source: geekwire.com
- Juno Therapeuticsipo
Cell-therapy company ARCH helped found; IPO'd in December 2014 at a $4B+ valuation per GeekWire.
Source: geekwire.com
- Denali Therapeuticsipo
Neurodegeneration biotech co-founded with ARCH backing; Nelsen took a founding board seat per FierceBiotech coverage cited in search results.
Source: geekwire.com
Misses
Track record
Partners 10
- Robert Nelsen
Co-founder and Managing Director
Board seats
11 current
- Keith Crandell
Co-founder and Managing Director
Board seats
7 current
- Mark McDonnell
Managing Director
Board seats
No public record - Clinton Bybee
Co-founder & Managing Director, Emeritus
Board seats
1 current
- Steve Gillis
Managing Director
Board seats
3 current
- Kristina Burow
Managing Director
Board seats
10 current
- Corey Ritter
Partner
Board seats
4 current
- Paul Berns
Managing Director
Board seats
5 current
- Jay Markowitz
Senior Partner
Board seats
1 on record
- Jake Bauer
Venture Partner
Board seats
5 current
Reputation 2
No reputation score — basis not established for this firm.
- GeekWire: Nelsen named to Midas List
geekwire.com
- BioForward 2025 investor report (PDF)
cdn.prod.website-files.com
Contact
Published sources only
Published contact
- Website
- www.archventure.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with ARCH Venture Partners. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — Latest flagship ARCH Venture Fund XIII over $3B (2024) with multiple IPO hits (Illumina, Juno, Denali) and a co-founder with repeated Midas List presence; AUM not stated on a fetched primary page, so Tier 2 via fund size + hits. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for ARCH Venture Partners — provenance: GlassVC extended catalog, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Track record · Reputation
- [2]
FIRM SITE · ARCH Venture Partners — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
